Research Article| Volume 56, ISSUE 6, P406-410, September 15, 2004

The –1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity


      The –1438A/G single nucleotide polymorphism (SNP) lies just upstream of two alternative promoters for the 5-hydroxytryptamine type 2A (5-HT2A) receptor gene (HTR2A) and is in strong linkage disequilibrium with the 102T/C SNP. Both SNPs are associated with numerous psychiatric disorders and related phenotypes. A possible functional affect of the –1438A/G SNP might underlie associations of both linked SNPs with these neuropsychiatric disorders. A prior investigation into affects of this SNP on promoter function, lacking the more downstream promoter, found no significant difference with a reporter gene assay.


      To investigate possible functional effects of –1438A/G on either promoter, two different reporter gene assays were used in three cell lines.


      Promoter activity was consistently detected that, in the presence of the SV40 enhancer, was significantly greater in the presence of the A allele relative to the G allele but only in cell lines that express endogenous HTR2A, suggesting that transcriptional factor(s) and the presence of both promoters might be necessary to elicit this effect.


      These findings show that the –1438A/G SNP has the potential to modulate HTR2A promoter activity and might be the functional variant responsible for the associations of both SNPs with many neuropsychiatric phenotypes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Arranz M.J.
        • Munro J.
        • Sham P.
        • Kirov G.
        • Murray R.M.
        • Collier D.A
        • et al.
        Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.
        Schizophr Res. 1998; 32: 93-99
        • Balciuniene J.
        • Emilssson L.
        • Oreland L.
        • Petterson U.
        • Jazin E.E.
        Investigation of the functional effect of monoamine oxidase polymorphisms in human brain.
        Hum Genet. 2002; 100: 1-7
        • Bonnier B.
        • Gorwood P.
        • Hamon M.
        • Sarfati Y.
        • Boni C.
        • Marie-Christine H.B.
        Association of 5-HT2A receptor gene polymorphism with major affective disorders.
        Biol Psychiatry. 2002; 51: 762-765
        • Bray N.J.
        • Buckland P.R.
        • Hall H.
        • Owen M.J.
        • O'Donovan M.C.
        The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain.
        Mol Psychiatry. 2004; 9: 109-114
        • Chee I.S.
        • Lee S.W.
        • Kim J.L.
        • Wang S.K.
        • Shin Y.O.
        • Shin S.C
        • et al.
        5-HT2A receptor gene promoter polymorphism –1438A/G and bipolar disorder.
        Psychiatr Genet. 2001; 11: 111-114
        • Chen K.
        • Yang W.
        • Grimsby J.
        • Shih J.C.
        The human 5HT2A receptor is encoded by a multiple intron-exon gene.
        Brain Res Mol Brain Res. 1992; 14: 20-26
        • Collier D.A.
        • Arranz M.J.
        • Li T.
        • Mupita D.
        • Brown N.
        • Treasure J.
        Association between 5-HT2A gene promoter polymorphism and anorexia nervosa.
        Lancet. 1997; 350: 412
        • Ding G.
        • Toth M.
        • Zhou Y.
        • Parks C.
        • Hoffman B.J.
        • Shenk T.
        Glial cell-specific expression of the serotonin 2 receptor gene.
        Brain Res Mol Brain Res. 1993; 20: 181-191
        • Du Y.L.
        • Wilcox B.D.
        • Teitler M.
        • Jeffery J.J.
        Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter constitutive and inducible activity in myometrial smooth muscle cells.
        Mol Pharmacol. 1994; 45: 1125-1131
        • Enoch M.A.
        • Goldman D.
        • Barnett R.
        • Sher L.
        • Mazzanti C.M.
        • Rosenthal N.E.
        Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, −1438A/G.
        Mol Psychiatry. 1999; 4: 89-92
        • Filip M.
        • Nowak E.
        • Papla I.
        On the role of serotonin 2A/2C receptors in the sensitization of cocaine.
        J Physiol Pharmacol. 2001; 52: 471-481
        • Hrdina P.D.
        • Du L.
        Levels of serotonin receptor 2A higher in suicide victims?.
        Am J Psychiatry. 2001; 158: 147-148
        • Ismaiel A.M.
        • Arruda K.
        • Teitler M.
        • Glennon R.A.
        Ketanserin analogies.
        J Med Chem. 1995; 38: 1196-1202
        • Kouzmenko A.P.
        • Hayes W.L.
        • Pereira A.M.
        • Dean B.
        • Burnet P.W.J.
        • Harrison P.J.
        5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia.
        Lancet. 1997; 349: 1815
        • Kouzmenko A.P.
        • Scaffidi A.
        • Pereira A.M.
        • Hayes W.L.
        • Copolov D.L.
        • Dean, B.
        No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia.
        Hum Hered. 1999; 49: 103-105
        • Leysen J.E.
        • Awouters F.
        • Kennis L.
        • Laduron P.M.
        • Vandenberk J.
        • Janssen P.A.
        Receptor binding profile of Ketanserin (R 41 468), a novel antagonist at 5-HT2 receptors.
        Life Sci. 1981; 28: 1015-1022
        • Pazzagli M.
        • Devine J.H.
        • Peterson D.O.
        • Baldwin T.O.
        Use of bacterial and firefly luciferases as reporter genes in DEAE-dextran-mediated transfection of mammalian cells.
        Anal Biochem. 1992; 204: 315-323
        • Polesskaya O.O.
        • Sokolov B.P.
        Differential expression of the “C” and “T” alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics.
        J Neurosci Res. 2002; 67: 812-822
        • Sabol S.Z.
        • Hu S.
        • Hamer D.
        A functional polymorphism in the monoamine oxidase A gene promoter.
        Hum Genet. 1998; 103: 273-279
        • Saltzman A.G.
        • Morse B.
        • Whiteman M.M.
        • Ivanshchenko Y.
        • Jaye M.
        • Felder S.
        Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes.
        Biochem Biophys Res Commun. 1991; 181: 1469-1478
        • Shih J.C.
        • Zhu Q.
        • Chen K.
        Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene.
        Behav Brain Res. 1996; 73: 59-62
        • Sorbi S.
        • Nacmias B.
        • Tedde A.
        • Ricca V.
        • Mezzani B.
        • Rotella C.M.
        5-HT2A promoter polymorphism in anorexia nervosa.
        Lancet. 1998; 351: 1785
        • Sparkes R.S.
        • Lan N.
        • Klisak I.
        • Mohanda T.
        • Diep A.
        • Kojis T
        • et al.
        Assignment of a serotonin 5HT-2 receptor gene to human chromosome 13q14-q21 and mouse chromosome 14.
        Genomics. 1991; 9: 461-465
        • Spurlock G.
        • Heils A.
        • Holmans P.
        • Williams J.
        • Dsouza U.M.
        • Cardno A
        • et al.
        A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.
        Mol Psychiatry. 1998; 3: 42-49
        • Turecki G.
        • Briere R.
        • Dewar K.
        • Antonetti T.
        • Lesage A.D.
        • Seguin M
        • et al.
        Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide.
        Am J Psychiatry. 1999; 156: 1456-1458
        • Williams J.
        • McGuffin P.
        • Nothen M.
        • Owen M.J.
        • Spurlock G.
        Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia.
        Lancet. 1997; 349: 1221
        • Zhu Q.
        • Chen K.
        • Shih J.C.
        Characterization of the human 5HT2A receptor gene promoter.
        J Neurosci. 1995; 15: 4885-4895